With the advent of next-generation sequencing technology, rare variant association analysis is increasingly being conducted to identify genetic variants associated with complex traits. In recent years, significant effort has been devoted to develop powerful statistical methods to test such associations for population-based designs. However, there has been relatively little development for family-based designs although family data have been shown to be more powerful to detect rare variants. This study introduces a blocking approach that extends two popular family-based common variant association tests to rare variants association studies. Several options are considered to partition a genomic region (gene) into ''independent'' blocks by which information from SNVs is aggregated within a block and an overall test statistic for the entire genomic region is calculated by combining information across these blocks. The proposed methodology allows different variants to have different directions (risk or protective) and specification of minor allele frequency threshold is not needed. We carried out a simulation to verify the validity of the method by showing that type I error is well under control when the underlying null hypothesis and the assumption of independence across blocks are satisfied. Further, data from the Genetic Analysis Workshop 17 are utilized to illustrate the feasibility and performance of the proposed methodology in a realistic setting.
Introduction
Genome-wide association studies (GWAS) have been extremely successful in identifying a bounty of common genetic variants linked to complex diseases and traits in the human population. While the identification of many novel variants associated with many traits has been a great accomplishment of GWAS, these genetic variants usually have small effect sizes and only account for a small proportion of the phenotypic variation. For example, height has been a well-known heritable quantitative trait with an estimated 80{90% of the variation attributed to genetic factors [1] , yet recent studies detected quite a number of loci that together only account for approximately 45% of the overall height variance [2] . Such observations have led to the hot topic of ''missing heritability'' [3, 4] and demonstrated the necessity of exploring other types of genetic variation that may account for unexplained heritability. With the ability to sequence the entire genome deeply, researchers have been looking beyond common sequence differences and interrogating rare single-nucleotide variations (rSNVs), i.e. variants of low minor allele frequency (MAF) , that can contribute substantially to complex diseases. Therefore, many recent studies have focused on the possible contribution of rSNVs and they have hypothesized that some portion of this rare variation underlies much of the unexplained heritability of many complex traits [5] .
Although assessing the role of rare variants in complex diseases is becoming increasingly feasible, detecting associations with rare variants still remains a challenging problem since rare variants are hard to pick up due to their low frequencies. Standard GWAS methods such as single-marker association tests are not appropriate strategies for detecting these low-frequency variants due to the fact that power diminishes with decreasing allele frequencies. As a result, a bevy of creative algorithms targeting rare variants have emerged. Such tests ''collapse'' information from rSNVs within a gene, a genomic region, a pathway, or some other defined properties. Without loss of generality and for ease of reference, we use genomic region when discussing such tests. Burden tests constitute a big portion of the existing literature [6] [7] [8] [9] . These methods aim to maximize the power to detect causal variants by combining information across variants in a target genomic region which may be a gene or other functional unit. These tests provide a significant improvement over single-marker tests since each individual rare variant can make only a small contribution to the overall disease prevalence or trait variance, whereas their aggregate effect may constitute a significant attributable risk. While each of these burden tests differs in form, they all suffer from power loss when both protective and risk variants are present in the region of interest. Consequently, several methods that are robust to the direction and magnitude of the effects of causal variants have been proposed such as data-adaptive methods [10] and variance component based method (SKAT) that test the variance rather than the mean [11] . Recently, Lee et al [12] have proposed an unified approach that maximizes power by adaptively using the data to optimally combine the burden test and the nonburden SKAT test.
Investigators often use either population-based or family-based sampling designs to study the genetic basis of complex diseases. A population-based design samples affected and unaffected individuals who are unrelated, such as case-control samples. Almost all the methods proposed in the literature for detecting rare variant associations, including those discussed above, are for case-control studies. On the other hand, a family-based design treats a family as a sampling unit, which can be as simple as trios or as complex as large extended pedigrees with potentially multiple affected individuals per pedigree. For family studies, half of the offspring are expected to inherit a copy of the minor allele from a parent who has a copy of it. Therefore, variants that are rare in the general population could be quite common in certain families and are potentially more informative. Aggregation-based rare variant tests for analyzing family-data, however, are very limited and in fact only a handful have been proposed to date. Zhu et al. (2010) [13] propose a two-stage method that utilizes part of the data set to co-classify rare risk haplotypes either by unrelated-case or affected sibpair design, while the rest is used for association testing. It was demonstrated that the affected sibpair design has better power to co-classify rare risk haplotypes than the unrelated-case design due to the risk haplotype frequencies being more enriched in affected sibpairs than in affected cases. Similarly, Feng et al [14] developed a sibpair-based weighted sum statistic to detect both rare and common risk variants residing in a gene or a genomic region. Neither method models phenotypic or genetic correlations between related individuals and they cannot be used to analyze pedigree samples. Natural extensions of existing tests for population-based designs to family designs have also taken place in the literature. Two recent studies extended the idea of SKAT to family data [15, 16] , but they only deal with quantitative traits. There is also an extension of a popular family-based association test (FBAT) to test for variants jointly over a region of interest [17] . Although the method can be used for both quantitative and qualitative traits, it relies on sometimes unrealistic assumption that all variants have effects in the same direction.
Due to low allele frequencies, it is hypothesized that rare variants do not exhibit strong linkage disequilibrium (LD) with either rare or common SNVs [18, 19] . Therefore, it has been argued in the last few years that rare rSNVs are independent, however, recent studies revealed that such an assumption is extremely liberal and can lead to significant inflation of type I error [20] . On the other hand, collapsing all rSNVs over a wide region and correcting for their dependence in an ad-hoc manner can lead to loss of power, since distant rSNVs are likely to exhibit independence, or at least such an assumption is not grossly violated. To balance the two extremes so that distant independence can be harnessed without sacrificing type I error, in this paper, we propose a blocking approach by assuming distant SNVs (i.e. SNVs between different blocks) are independent whereas dependency of SNVs within a block is taken into account. The proposed methodology does not require any assumptions about the directions of effect or the effect sizes of rare genetic variants in the region. Further, the approach can analyze all SNVs (rare or common) within a genomic region to avoid a preset threshold for rare variants. This is clearly an advantage over methods that require the specification of such a threshold as such methods are shown to be sensitive to the selection. Another important advantage of the proposed method inherited from family-based designs is its robustness to population stratification. The blocking approach is developed for two popular familybased common variant association tests for binary traits: PDT and FBAT. We evaluated the proposed methods based on simulation and application to the Genetic Analysis Workshop 17 data. Comparisons with two FBAT extensions to rare variants by De et al. [17] were also carried out.
Materials and Methods
Family-based Association Tests -PDT and FBAT for a Single SNV
In this subsection, we first briefly describe two popular familybased tests, Pedigree Disequilibrium Test (PDT, [21] ) and FamilyBased Association Test (FBAT [22] ), that are applicable to general pedigree data for testing for association in the presence of linkage. At the end of this subsection, we also describe two recent extensions of FBAT [17] for testing the aggregate effects of rSNVs. Our proposed rare blocking methods (rbPDT and rbFBAT) will be presented in the next subsection. Let N be the total number of pedigrees and n i be the number of non-founders in the i th pedigree. Let Y ij and X ij denote the trait value and the genotype score at the given SNV of the j th nonfounder in the i th pedigree, respectively, where i~1,2, . . . ,N; j~1,2, . . . ,n i . We assume that all N pedigrees in the data set are independent. In this study, we consider a binary trait where 1 is case and 0 is control. At each SNV, genotype score is coded as 0, 1 and 2 to represent 0, 1 or 2 copies of minor allele.
The general test statistic for FBAT uses the covariance between the traits and the genotypes as a measure of association. Specifically,
) and the covariance in the formula is computed conditional on the traits and the sufficient statistic assuming the null hypothesis is true. Under the null hypothesis of no association, T FBAT follows the standard normal distribution for large samples.
The PDT considers trios and discordant sibpairs in each pedigree. For a given SNV with two alleles M 1 and M 2 , we define X T m~( #M1 parental alleles transmitted)-(#M1 parental alleles not transmitted), for the m th trio with an affected child and X Sm~( # M1 alleles in affected sib)-(# M1 alleles in unaffected sib) for the m th discordant sibpair. Then the PDT test statistic is
i , and n t (i) and n s (i) denote the number of informative nuclear families (consisting of one affected child and two parents) and discordant sibpairs (consisting of one affected sibling and one unaffected sibling), respectively, for the i th pedigree. Under the null hypothesis of no association, T PDT follows the standard normal distribution.
Family-based Rare Association Tests -FBAT for Multiple SNVs
As in population-based approaches, single-SNV statistics may lack power to detect associations with rare variants. De et al [17] recently proposed a method that extends the FBAT statistic to test for rare variants by collapsing variants within a genomic region. More specifically, if there are p variants within the region, then T FBAT (k) represents the value of the FBAT statistic for SNV k~1,2, . . . ,p and the modified FBAT statistic for rare variants is defined as the sum of these p statistics. The standardized test statistic is obtained by dividing this sum by its standard deviation which is calculated using the correlation matrix estimate suggested by Rakovski et al. [23] .
De et al. [17] considered analyzing either only rare variants using a fixed threshold or all variants within the region of interest using a weighting scheme. In the former, one can use a threshold value based on allele frequencies to identify a subset of variants as rare and consider the analysis on only that subset. Although 1% and 5% are the most conventional choices, setting the threshold too low may exclude some rare causal variants (those whose frequencies are above the threshold), yet setting it too high may include too many non-causal variants. Either way can potentially lead to loss of power. There may be further power loss if there are common causal variants. Alternatively, a weighting scheme based on allele frequencies is also proposed for joint analysis of common and rare variants. Throughout this paper, fbatv0 and fbatv1 denote the fixed threshold (using only rSNVs) and the allele frequency weighted (using all SNVs) approaches, respectively.
rbPDT and rbFBAT -Blocking Approaches for Multiple SNVs
We propose a novel collapsing idea that can be incorporated into standard family-based tests PDT and FBAT. The idea is to balance the two extreme assumptions (all independence, or all dependence, of SNVs) that existing methods rely on by hypothesizing that distant SNVs are independent while dependency exists among nearby SNVs. In this approach, a genomic region is divided into blocks and SNVs within each block are aggregated to arrive at a statistic. Further aggregation is then performed across blocks but the block statistics are now assumed to be independent in the second layer of aggregation. The approach analyzes rare and common SNVs jointly and does not require a particular MAF threshold selection.
Suppose there are B blocks spanning the genomic region within which aggregate effect of the SNVs will be assessed. Details of the how to construct these blocks will be provided in the following subsection. Now consider block b,b~1, Á Á Á ,B, and assume that there are p SNVs within the block. We consider a family-based test statistic (i.e. FBAT or the PDT) for the i th pedigree and k th SNV as described in the previous section and denote it as D ik , i~1,2, . . . ,N; k~1,2, . . . ,p. Then we define Q 
denotes the standardized statistic utilizing information from all SNVs within block b for all pedigrees, which follows a standard normal distribution approximately assuming N is sufficiently large. We then sum over information from all B blocks to arrive at the following overall test statistic:
Assuming the T b 's are independent, the statistic T follows a chisquare distribution with B degrees of freedom. If the i th pedigree PDT statistic (V i ) for the k th SNV is used as D ik , then the resulting method is called rare-blocking PDT, or rbPDT, while the one that uses the i th pedigree FBAT statistic (U i ) for the k th SNV is termed rbFBAT.
Blocking Schemes
Sliding-window approach that considers several neighboring SNVs together within a window frame is a popular strategy for collapsing methods. We borrow this simple idea by arranging all SNVs of interest into ''independent'' blocks. Each block can be viewed as a ''window'', while the window (block) size is determined by either the number of base-pairs (bp; the typical sense of a window) or by the number of SNVs (a novel concept). Determination of a good window size in either definition is an important but difficult problem as its choice can be influenced by factors such as LD patterns and MAF of the causal SNVs. Since it is not feasible to investigate the relationship between optimal window size and these factors analytically, we consider several reasonable options and evaluate how blocking schemes may affect the performance of rbPDT and rbFBAT empirically.
Although multiple genes (in the thousands) are being considered in this study, for simplicity, each blocking scheme with multiple window sizes are applied to all genes to gain an understanding of the overall performance so that general recommendation can be made. For example, if the window size is set to be 5 kb, then all genes are partitioned into 5 kb blocks. Note that this blocking scheme may result in different number of blocks for different genes since gene lengths vary. Another possible approach is to specify the number of blocks and divide each gene (large or small) into that many blocks. Unlike the former approach, this may result in blocks of difference sizes in different genes, also depending on gene lengths. Similar phenomenon applies to the scenario when ''window size'' is defined as the number of SNVs it contains. One way of constructing such blocks is to fix the number of SNVs in each block (e.g. 2 SNVs per block). Note that this will result in different number of blocks depending on the gene size and SNV density. Another way is to fix the number of blocks and partition all SNVs into the specified number of blocks so that each block has the same number of SNVs. This may result in different sizes (i.e. different number of SNVs in each block) across genes. These ideas lead to the following four options that are employed in the analyses carried out in this paper. The numbers in parentheses specify the number of blocks or window size (which can either be in bp or in number of SNVs depending on which definition of window size is being used). To further clarify and deal with unconventional situations, we note that Options 1 and 2 use bp to define a window size whereas the window size used in Options 3 and 4 is number of SNVs. In each case, one can either fix the number of blocks or the window size when constructing blocks. If the gene length (either in bp or in number of SNVs) is less than or equal to a specified window size, then only one block is formed for Options 1 and 3. When Option 2 is employed, only blocks containing at least one SNV are kept for further analysis since some blocks may not contain any SNVs. If the number of SNVs within a gene is less than the specified number of blocks under Option 4, it constructs blocks to have one SNV in each block. That is, the number of blocks for that gene is set to be equal to the number of SNVs within the gene. Therefore, for fixed number of blocks options (both 2 and 4), it is possible that some genes are divided into fewer number of blocks than the prespecified number. A comprehensive comparison of these blocking strategies will be provided in the Results section.
Genetic Analysis Workshop 17 Data
The Genetic Analysis Workshop 17 (GAW 17) mini-exome data contain genotypes for 697 unrelated individuals on 24,487 variants (in 3,205 genes) from the 1000 Genomes Project. The workshop also distributed data on 8 extended pedigrees composed of 697 individuals. Of the 202 founders, their genotypes were assigned based on a random sample from the 697 unrelated individuals, which turned out to include 12 CEPH (European-descent residents of Utah), 18 Denver Chinese, 19 Han Chinese, 28 Japanese, 50 Luhya, 66 Tuscan, and 9 Yoruban individuals. As such, there exists population admixture. These genotypes are then dropped down to form the genotypes of non-founders, leading to [24] . Our numerical analysis starts with a simulation study designed to evaluate type I error and power for rbPDT, rbFBAT, fbatv0 and fbatv1 under different scenarios. In this simulation, we generated genotype and phenotype data utilizing the same pedigree structures as in the GAW 17 data. After the simulation demonstrating the validity of the proposed methodologies, we performed two sets of analyses of the GAW 17 data. In the first set of analyses, we investigate how blocking schemes with various window sizes and block numbers may affect the outcomes of rbPDT and rbFBAT by using only the first replicate of simulated phenotypes. This analysis also provides an evaluation of the effectiveness of rbPDT and rbFBAT for detecting rare variants using a realistic data set. The second set of analyses is carried out to compare the performances of rbPDT and rbFBAT with those of fbatv0 and fbatv1 using phenotype data from all 200 replicates. For each gene, we set its length to equal the difference between the largest and the smallest base-pair locations of SNVs contained in the gene. With this definition, the majority of these 3,205 genes have length less than 105 kb with 30 or fewer SNVs.
Results

Simulation Study: Type I Error and Power
To verify the validity of the proposed blocking methods and to compare them with recently proposed state-of-art methods for family-based studies in a controlled setting, we perform a simulation study in which the family structure from GAW 17 data is replicated 10 times to create 80 families so that the sample size is sufficiently large to draw definitive conclusions, especially on the type I error. We simulated 1000 sets (replicates) of genotype data for the founders, which consists of 20 SNVs modeled after the LPL gene provided in the GAW 17 data and with linkage disequilibrium (LD) setting that utilizes a block diagonal correlation matrix assuming there are 5 independent blocks. Within each block containing 4 SNVs, LD correlation between farther SNVs decays following an autoregressive model with r~0:7. Under this setting, the optimal blocking is the one that divides the SNVs in groups of 4 SNVs, i.e. Option 4 of our blocking schemes with 5 blocks, as it preserves the independence assumption across blocks. Haplotypes for unrelated founders with desired MAF and LD structure are simulated using the same procedure as in HapSim [25] , then we passed down the haplotypes to the remaining individuals assuming no recombination. For each set of genotypes, the binary disease status for each individual was simulated using the model
where X i and Y i denote the genotype and trait values for the i th individual. Type I error was calculated using the model with b 0~{ log(10) and b~0, while b is set to be either (2,2,2), (2,{2,2), (3, 3, 3) or (3,{3,3) for three (as in the LPL gene) randomly selected causal variants. This process is repeated 1000 times to create 1000 data sets to investigate the size and power under settings with different effect size and directions. Results for fbatv1 using allele frequency weights, fbatv0 with three different MAF thresholds (0:005, 0:01, and 0:05), rbPDT and rbFBAT with one specification for each option (i.e., 5 kb for Option 1, 5 SNVs for Option 3, and 5 blocks for Options 2 and 4) are reported in Table 1 with the significance a-level set to be 0:01. We also include the one-block (i.e. no blocking) option as a comparison. Since the actual type I error rates are not comparable across different methods, we adjusted the critical value so that all tests have the same 1% error rate to compute the power reported in Table 1 .
The results indicate that type I error is maintained with a nominal a{level of 0:01 when the between-block-independence assumption is satisfied (Table 1, Option 4 for both rbPDT and rbFBAT). When the assumption of independence between blocks is violated (as in Options 1-3), there can be some inflation of type I error (especially Option 1 under rbFBAT). However compared to the one-block approach, the type I error is better under controlled. On the other hand, The fbatv0 with all MAF thresholds and fbatv1 are a bit conservative. As expected, power increases with effect sizes in all methods. When SNVs have opposite effect directions, substantial power loss is observed for fbatv0 and fbatv1, while the power based on blocking approaches remains comparable with the power of the same direction effect sizes.
Analysis of GAW 17 Data
Analysis I. In the first analysis, different blocking options with various specifications are compared utilizing the disease status from the first replicate. Specifically, two fixed window size and two fixed number of blocks are used with varying window size and number of blocks: Option 1 (2,3,4,5 or 6 kb), Option 2 (2, 3, 5, 7, 10 blocks), Option 3 ((2, 3, 5, 7, 10 SNVs) and Option 4 (2, 3, 5, 7, 10 blocks).
The results are provided in Figures 1 and 2 . Here, true positive rate (TPR; power) is defined as the proportion of all causal genes that are found to be significant, i.e. (total number of true positives)/36, whereas the false positive rate (FPR; type I error) is the proportion of all non-causal genes that are found to be significant, i.e. (total number of false positives)/(3205-36). Figure 1 show the receiver operating characteristic (ROC) curves obtained by rbPDT for the different options with different size or number of blocks selections. The a{level significance is between 0 and 1 with 0:01 increments. Different choices of window size result in more fluctuations for blocking using the fixed number of SNVs (Option 3) than the blocking using fixed number of bp's (Option 1). One possible explanation for this might be that since most of the gene lengths are 105 kb or less, dividing them into 2, 3, 4, 5, or 6 kb blocks yields similar partitions containing the same set of SNVs especially if SNVs are densely distributed along the gene. On the other hand, splitting SNVs of a gene into blocks with different number of SNVs may result in quite altered separations. Two fixed number of blocks approaches, Options 2 and 4, produce more variations compared to their block size counterparts, Options 1 and 3. This is not surprising since different number of blocks are more likely to create variations in building blocks especially when the number of SNVs within the gene or gene length is large. Nevertheless, despite these variations, all blocking methods with different size selections yielded very close power and type I errors especially when FPR is small (lower-left corner of Figure 1 ). Results based on rbFBAT are illustrated by ROC curves in Figure 2 . Like rbPDT, rbFBAT results are more stable for Option 1 than Option 3 while both yield less variation than their counterparts with a fixed number of blocks (Option 1 vs. Option 2, and Option 3 vs. Option 4). Performances of rbPDT and rbFBAT are very comparable as shown by the figures. Overall, Figures 1  and 2 indicate that rbPDT and rbFBAT are at par and blocking scheme selection might have an effect on the results especially depending on the distribution of gene lengths and number of SNVs within the genes.
To further investigate the effect of blocking, we select 3 causal genes (INSIG1, LPL, PIK3C2B) containing small, moderate and large number of SNVs (5, 20 and 71) and 3 causal genes (RRAS, HIF3A, PRKCB1) with small, moderate and large lengths (1:29, 28:24, and 383:87 kb). The p-values for these genes obtained from rbPDT are listed in Table 2 for all options with different size selections. We omit results from rbFBAT for brevity since the inferences are quite similar. It can be seen that Option 1 results for different window sizes vary less compared to Option 3 results, consistent with the observations made from Figures 1 and 2 . We believe that this is due, in part, to the fact that Option 3 produces varying number of blocks and thus containing different sets of SNVs yielding a range of p-values. In general, it appears that for small to moderate size genes containing small to moderate number of SNVs, the p-value tends to get larger as the number of blocks increase, leading to reduction in power. Therefore, for such genes, blocking schemes leading to a small number of blocks might be a better option. This is especially true if most of the causal SNVs are rare and combining as many as possible can strengthen the signals. These inferences are particularly true for genes INSIG1, LPL, RRAS. Although HIF3A is also a moderately large gene with moderate number of SNVs, it is not true that small number of blocks yield optimal results. When we look at this gene more closely, we see that SNVs are sparsely distributed along the gene, so setting a small number of blocks results in including distant SNVs in the same block. Since, in general, it is more likely to observe sparsely located SNVs for larger genes, such as PIK3C2B, options with smaller number of blocks may not work as in small genes. In such cases, one should consider an option that will produce a reasonable number of blocks such that distant SNVs are not combined into same block yet close SNVs are not separated. This finding shows that, beside the gene length and SNV number within the gene, how closely SNVs are spaced on the gene is another important factor that can create variations for different size selections. In Figure 3 , the base pair locations of the 6 SNVs in the RRAS gene (a small one) and 20 SNVs in the PRKCB1 gene (a larger one) are plotted. For the RRAS gene, although there are two visible clusters, as can be seen in Figure 3 (a), they are not far separated since the gene is very small. At the same time, since both of the causal SNVs are very rare (MAF = 0:001435), constructing one block (including all 6 SNVs) provides more power than the two blocks scheme does. On the other hand, SNVs located in PRKCB1 are very sparse. Obviously, very large number of blocks (see Option 1 results for PRKCB1) is not a good approach due to its large degrees of freedom. Very small number of blocks may not be the right choice either. For instance, the smallest p-value of 0:006 is obtained by Option 4 with three blocks while the p-value for two block approach is 0:0232. The latter leads to the observation that there may be power loss if distant non-causal SNVs are grouped together with causal ones into the same block.
Analysis II. In the second set of analysis, we compare the performance of rbPDT and rbFBAT with two recently proposed methods, fbatv0 and fbatv1 [17] . We chose fbatv0 and fbatv1 since they are also extensions of FBAT and software implementations are available (beta version of FBAT v2.0.4). We set the MAF threshold for fbatv0 as 0:01 and use the weighting scheme based on allele frequencies as described in [17] for the fbatv1. We utilized all 200 replicates to construct ROC curves for each method. For rbPDT and rbFBAT, only one representative from each option (i.e., [17] in that fixed threshold approach fbatv0 is highly dependent on the choice of the MAF threshold while weighted no threshold approach fbatv1 avoids such choice problem and outperforms fbatv0. On the other hand, both blocking methods, rbFBAT and rbPDT, perform similarly and are better than the two fbat versions. These findings are further substantiated by the boxplots shown in Figure 5 , in which area under the ROC curves (AUC) for 200 replicates are shown for each of the method and blocking options. It can be seen that fbatv0 and fbatv1 are clearly outperformed by rbPDT and rbFBAT with any of the four blocking options. Further, rbPDT and rbFBAT continue to be similar evaluated by AUC.
Discussion
Family-based designs have important advantages over population-based methods, especially in their robustness to population stratification. Motivated by this, we extend two popular familybased association approaches originally proposed for common variants, PDT and FBAT, to test for association with rare variants. These approaches (rbPDT and rbFBAT) are based on splitting a given genomic region (e.g. gene) into blocks under the assumption that SNVs between different blocks are independent while dependency among SNVs within a block is being taken into consideration. A statistic for each block is calculated using the SNVs located within the block and statistics across these blocks are combined to arrive at an overall test statistic for the genomic region of interest. An inherent assumption for our test statistic to be valid is that the statistics across blocks that summarize information from multiple SNVs are independent. However, dependency among SNVs within a block is allowed and accounted for. As such, the proposed methodology may be viewed as a compromise between methods that assume independence of all rare SNVs and those that depict dependency of all variants within a region. This compromise can lead to increase in power by ''creating independent data'' while holding the type I error rate at base since it still accounts for dependency in a proper fashion. As an further advantage, our methods do not require an MAF threshold and can analyze rare and common variants jointly. We show that, based on ROC (AUC) evaluations, rbPDT and rbFBAT perform similarly and reasonably well compared to two recently proposed family-based methods, fbatv0 and fbatv1, for detecting rare variants. For a fixed significance level (e.g. a~0:01), rbPDT and rbFBAT may outperform each other under different blocking options, but they consistently outperform fbatv0 and fbatv1. More importantly the empirical type I error rates of both rbPDT and rbFBAT are close to the nominal level specified when the underlying assumptions for the validity of the asymptotics are satisfied.
Blocking option and blocking parameter (size or number of blocks) unquestionably play an important role in the implementations of rbPDT and rbFBAT. The optimal choice of blocking depends on mechanisms that are unknown in practice. Our empirical results indicate that gene length, number of SNVs within a gene, and density of SNVs are among factors that may affect the performance of blocking-based methods. As such, we believe that blocking selection should be done in a data adaptive way. For a small to moderately sized gene containing a small to moderate number of tightly scattered SNVs, options with a small number of blocks should be considered. For a large-size gene including many SNVs or moderately large gene with sparsely located SNVs, a large number of blocks will inflate the degrees of freedom whereas a small number of blocks might lead to blocks with distant SNVs. In such cases, selecting the right number of blocks is the key. Another idea in real data analysis (where the underlying truth is unknown) is to use a hierarchical clustering method based on data to partition the genomic region into blocks if the sample size is large and LD within block is strong. We illustrated this by considering a data set with 200 families (GAW 17 family structure is replicated 25 times) simulated in the same way as in our validity study with correlation between adjacent SNVs set to be 0:7. The output of the average-linkage clustering on the genome data is displayed graphically in Figure 6 , conveying the existence of five clusters of SNVs 1-4, 5-8, 9-12, 13-16, and 17-20, recovering the grouping scheme in the simulation. If computational intensity in a genome-wide study prevents the selection of a blocking scheme in a data adaptive way, that is automation is desired for practical purpose, then options with a fixed number of blocks may be considered since that would allow an investigator to control the number of blocks.
Another important feature of the proposed methodology is its suitability for detecting association when a mixture of protective and risk variants are involved. The proposed methodology squares the SNV scores before adding them up to prevent cancelation of opposite effects within a block. The advantage of this feature is clearly seen in our simulation results displayed in Table 1 . That is rbPDT and rbFBAT outperform fbatv0 and fbatv1, both of which are susceptible to different directional effects.
There are still many challenges in understanding the involvement of rare variants in complex disease etiology. Given the limited availability and underdevelopment of statistical methods for analyzing family data for detecting rare variant association, we believe that rbPDT and rbFBAT provide much needed and viable alternatives. Such methods are important in the hunt for rare variant association given the potential enrichment of rare variants in family data and their insensitivity to population stratification.
